Clinical Research for Milk Thistle and Hemochromatosis

Clinical Research for Milk Thistle and Hemochromatosis:
  • Abenavoli L, Capasso R, Milic N, Capasso F. Milk Thistle in Liver Diseases: Past, Present, Future. Phytother Res. 2010 Oct;24(10):1423-32. doi: 10.1002/ptr.3207. PMID: 20564545
  • Bares JM, Berger J, Nelson JE, et al. Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C. J. Clin. Gastroenterol. 2008;42(8):937-944.
  • Gharagozloo M, Moayedi B, Zakerinia M, et al. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial. FundamClinPharmacol. 2009;23(3):359-365.
  • Hutchinson C, Bomford A, Geissler CA. The Iron-Chelating Potential of Silybin in Patients with Hereditary Haemochromatosis. Eur J Clin Nutr. 2010 Oct;64(10):1239-41. doi: 10.1038/ejcn.2010.136. Epub 2010 Jul 14. PMID: 20628405
  • Bell, Warren. What’s in a Name? Can Fam Physician. 2008 Feb; 54(2): 183–185. PMCID: PMC2278302
  • Kidd R. Exacerbation of Hemochromatosis by Ingestion of Milk Thistle. Can Fam Physician. 2008 Feb;54(2):182; author reply 182-3. PMID: 18272626
  • Whittington C. Exacerbation of hemochromatosis by ingestion of milk thistle. Can Fam Physician. 2007;53:1671–3. PMID: 17934030